An error occurred retrieving content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
Eplerenone was not superior to placebo in improving best-corrected visual acuity after 12 months in people with chronic central serous chorioretinopathy.
1 Department of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
2 NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK
3 Bristol Trials Centre Clinical Trials and Evaluation Unit (BTC-CTEU), Bristol Royal Infirmary, University of Bristol, Bristol, UK
4 Liverpool Ophthalmic Reading Centre, St. Paul’s Eye Unit, Royal Liverpool University Hospitals NHS Trust, Liverpool, UK
5 Centre for Vision Sciences, Queen’s University Belfast, Belfast, UK
* Corresponding author Email: a.j.lotery@soton.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation: {{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al.' : ''}} . {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.